Wegovy Helps HFpEF Patients With Diabetes Mellitus
(MedPage Today) -- ATLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) who have type 2 diabetes, the STEP-HFpEF DM trial showed... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran added to standard of care antihypertensives in patients with inadequately controlled hypertension
The KARDIA-2 study met its primary endpoint demonstrating additive, placebo-adjusted systolic blood pressure reductions of up to 12.1 mmHgat month three. These results were statistically significant and clinically meaningfulZilebesiran demonstrated an encouraging safety and tolerability profile when added to standard of care antihypertensives Basel, 7 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam today released detailed results from the Phase II KARDIA-2 study evaluating the efficacy and safety of a single subcutaneous dose of zilebesiran when added to one of three standard of care (SOC) antihypertensives. T...
Source: Roche Investor Update - April 7, 2024 Category: Pharmaceuticals Source Type: news
Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitor
(MedPage Today) -- ATLANTA -- The SGLT2 inhibitor empagliflozin (Jardiance) did not exactly prevent deaths and heart failure (HF) events when initiated atop other standard therapies for acute myocardial infarction (MI), the EMPACT-HF trial found... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
Interatrial Shunt's Prospects in Heart Failure Shrink After RELIEVE-HF
(MedPage Today) -- ATLANTA -- An interatrial shunt failed to provide a clinical benefit to people with heart failure (HF) overall in the RELIEVE-HF trial, though actual harm or benefit seemed to hinge on the patient's left ventricular ejection... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
Miracle diabetes jab Ozempic 'halves severe heart failure symptoms' in 'paradigm shift' in battle against deadly condition
Celebrities like Elon Musk (pictured) have admitted to taking the miracle diabetes jab Ozempic in a bid to slim down. (Source: the Mail online | Health)
Source: the Mail online | Health - April 6, 2024 Category: Consumer Health News Source Type: news
Study shows Wegovy easing heart failure symptoms for patients with diabetes
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity. Patients who took Wegovy reported less fatigue, less leg swelling, were…#novonordiskas #novo #danish #jama (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Wegovy ’s heart benefits are not just linked with weight loss, new study suggests
People with obesity-related heart failure and diabetes can get substantial heart-health benefits from weight-loss drug Wegovy, even if they don’t shed many pounds on the medication, according to new research. (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Novo ’s Wegovy Aids Heart Failure Patients With Diabetes in Study
(Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
SGLT2 Inhibitors Safe for HF in Congenital Heart Disease SGLT2 Inhibitors Safe for HF in Congenital Heart Disease
SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2024 Category: Cardiology Tags: Cardiology Source Type: news
From headaches, flatulence and now heart failure, ALL the health complications linked to vaping - and why it's NOT as safe as you might think
Calls for further action on vaping in Britain comes as yet another study suggests using vapes increases the risk of serious health complications, this time of heart failure. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2024 Category: Consumer Health News Source Type: news
SPECT/CT algorithm predicts heart failure hospitalizations
This study represents the first evidence, to our knowledge, demonstrating that integrating SPECT MPI into an AI-based risk assessment algorithm significantly improves the prediction of hospitalizations due to [heart failure],” the group wrote. The research was published March 28 in the Journal of Nuclear Medicine.Heart failure is a major cause of morbidity and mortality in the United States and worldwide, with prevalence projected to increase by almost 50% from 2012 to 2030, the authors wrote. They noted that identifying patients who are at risk for heart failure exacerbation can open opportunities for prevention strateg...
Source: AuntMinnie.com Headlines - April 3, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Artificial Intelligence Source Type: news
An AI Stethoscope ’s New Algorithm To Predict Heart Failure Gets FDA Clearance
Eko Health, which has developed digital stethoscopes that use AI to detect different heart conditions, received clearance for an algorithm that spots when hearts are pumping less than they should. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2024 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare AI /ai Editors' Pick editors-pick Premium Content premiumcontent technology alexknappblog Source Type: news
E-Cigarettes Tied to Heart Failure
(MedPage Today) -- Use of electronic nicotine products was associated with incident heart failure, a prospective study found.
People who self-reported ever having used electronic cigarettes (e-cigarettes) were 19% more likely to develop heart... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 2, 2024 Category: Cardiology Source Type: news
SGLT2i Better Than Diuretic for Early Decongestion in Acute Heart Failure?
(MedPage Today) -- Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual care, the DICTATE-AHF trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 2, 2024 Category: Cardiology Source Type: news
Fresh health warning over vaping as shock study finds e-cigarettes may raise risk of heart failure
Dr Yakubu Bene-Alhasan from MedStar Health in Baltimore, US, said the results suggested that those who use e-cigarettes were 19 per cent more likely to develop heart failure. (Source: the Mail online | Health)
Source: the Mail online | Health - April 2, 2024 Category: Consumer Health News Source Type: news
